Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikuo Inoue

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Diabetes|April 30, 2002
A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetesTakuya Awata, Kiyoaki Inoue, Susumu Kurihara, et al.
Stroke|December 25, 2004
A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemiaTomokazu Shimazu, Ikuo Inoue, Nobuo Araki, et al.
Biochemical and Biophysical Research Communications|January 18, 2006
Involvement of intestinal alkaline phosphatase in serum apolipoprotein B-48 level and its association with ABO and secretor blood group typesTakanari Nakano, Tomoko Shimanuki, Makoto Matsushita, et al.
Annals of Clinical Biochemistry|August 10, 2004
Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasmaTakanori Nakajima, Toshiyuki Matsunaga, Shin-Ichiroh Kawai, et al.
Metabolism: Clinical and Experimental|June 21, 2006
Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with impaired glucose toleranceIkuo Inoue, Yuichi Shinoda, Takanari Nakano, et al.
Npj Aging|March 20, 2025
Author Correction: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapyYuichi Ikegami, Ikuo Inoue, Kaiji Inoue, et al.
Nutrients|July 14, 2023
Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study)Yoshifumi Tamura, Hideyoshi Kaga, Yasuko Abe, et al.
Clinical Immunology (Orlando, Fla.)|September 17, 2019
Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9-23-related peptides in subtypes of type 1 diabetesYoichi Oikawa, Kumiko Sakamoto, Atsushi Satomura, et al.
NPJ Aging and Mechanisms of Disease|June 29, 2018
The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapyYuichi Ikegami, Ikuo Inoue, Kaiji Inoue, et al.
Journal of Clinical Biochemistry and Nutrition|October 2, 2009
Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in caco-2 cellsTakanari Nakano, Ikuo Inoue, Shigehiro Katayama, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Diabetes|April 30, 2002
A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetesTakuya Awata, Kiyoaki Inoue, Susumu Kurihara, et al.
Stroke|December 25, 2004
A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemiaTomokazu Shimazu, Ikuo Inoue, Nobuo Araki, et al.
Biochemical and Biophysical Research Communications|January 18, 2006
Involvement of intestinal alkaline phosphatase in serum apolipoprotein B-48 level and its association with ABO and secretor blood group typesTakanari Nakano, Tomoko Shimanuki, Makoto Matsushita, et al.
Annals of Clinical Biochemistry|August 10, 2004
Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasmaTakanori Nakajima, Toshiyuki Matsunaga, Shin-Ichiroh Kawai, et al.
Metabolism: Clinical and Experimental|June 21, 2006
Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with impaired glucose toleranceIkuo Inoue, Yuichi Shinoda, Takanari Nakano, et al.
Npj Aging|March 20, 2025
Author Correction: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapyYuichi Ikegami, Ikuo Inoue, Kaiji Inoue, et al.
Nutrients|July 14, 2023
Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study)Yoshifumi Tamura, Hideyoshi Kaga, Yasuko Abe, et al.
Clinical Immunology (Orlando, Fla.)|September 17, 2019
Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9-23-related peptides in subtypes of type 1 diabetesYoichi Oikawa, Kumiko Sakamoto, Atsushi Satomura, et al.
NPJ Aging and Mechanisms of Disease|June 29, 2018
The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapyYuichi Ikegami, Ikuo Inoue, Kaiji Inoue, et al.
Journal of Clinical Biochemistry and Nutrition|October 2, 2009
Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in caco-2 cellsTakanari Nakano, Ikuo Inoue, Shigehiro Katayama, et al.
Pageof 10